SpotSee
Spot See Life Sciences 6475f70e0e5ab

SpotSee adds intelligent sensor technology supplier

May 30, 2023
Sensor International’s patented indicators for life science and food safety markets provide low-cost, time-temperature detection capabilities.

SpotSee recently acquired unique temperature indicator technologies and intellectual property from Sensor International, which supplies intelligent indicator technologies that can be integrated into various products, packaging, medical devices, and diagnostics.

These patented technologies are particularly useful in life science, food safety, and high-pressure pasteurization markets, SpotSee said.

“SpotSee sees a tremendous opportunity with the Sensor Indicator technologies because of its low-cost, time-temperature detection capabilities that can mimic spoilage experienced in vaccine vial monitoring, pharmaceuticals and food,” Tony Fonk, president and CEO of SpotSee, said in a news release. “We look forward to working with the Sensor Indicator team to develop and commercialize these unique technologies into real world applications.”

This is the second acquisition by SpotSee announced in May, following the addition of Marathon Products in San Leandro, California, earlier in the month. The goal is to develop the best patient-focused life science solutions, as well as products for food distribution monitoring, SpotSee reported.

The World Health Organization (WHO) mandates that manufacturers utilize vaccine vial monitors, enabling millions of vaccines to reach rural patients throughout the globe without spoilage. Through the acquisition of Sensor International, SpotSee will continue its development of key solutions to support the distribution and monitoring of vaccine and temperature sensitive medication.

According to the IQVIA Institute for Human Data Science, 30% of cold chain products are scrapped because of cold chain issues.

“SpotSee is a purpose-driven company, and we are motivated to create unique technologies that help solve a global health problem,” Fonk concluded. “We are proud of our role to help reduce waste in the pharmaceutical supply chain.

“Imagine if we had 30% more medicine to reach those in need.”

About the Author

Commercial Vehicle Staff

Voice your opinion!

To join the conversation, and become an exclusive member of FleetOwner, create an account today!

Sponsored Recommendations

Leveraging telematics to get the most from insurance

Fleet owners are quickly adopting telematics as part of their risk mitigation strategy. Here’s why.

Reliable EV Charging Solution for Last-Mile Delivery Fleets

Selecting the right EV charging infrastructure and the right partner to best solve your needs are critical. Learn which solution PepsiCo is choosing to power their fleet and help...

Overcoming Common Roadblocks Associated with Fleet Electrification at Scale

Fleets in the United States, are increasingly transitioning from internal combustion engine vehicles to electric vehicles. While this shift presents challenges, there are strategies...

Report: The 2024 State of Heavy-Duty Repair

From capitalizing on the latest revenue trends to implementing strategic financial planning—this report serves as a roadmap for navigating the challenges and opportunities of ...